Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: A possible factor in the pathogenesis of infusion phlebitis

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 2, 2004, Pages 174-179

  Lanbeck, Peter ^a   Odenholt, Inga ^a   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Antibiotics; CD54; Phlebitis chemically induced

Indexed keywords

ABBOTICIN; CEFUROXIME; DICLOXACILLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERYTHROMYCIN STEARATE; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PENICILLIN G SODIUM; THROMBOPLASTIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRID CELL; INCUBATION TIME; PATHOGENESIS; PHLEBITIS; PROTEIN EXPRESSION; RISK FACTOR; UMBILICAL VEIN; UPREGULATION;

ANTI-BACTERIAL AGENTS; CELL LINE; DICLOXACILLIN; ENDOTHELIAL CELLS; ERYTHROMYCIN; FLOW CYTOMETRY; HUMANS; INFUSIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; PENICILLINS; PHLEBITIS; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 1242330266     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh056     Document Type: Article

References (30)

1. Maki, D. G. & Ringer, M. (1991). Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Annals of Internal Medicine 114, 845-54.
2. Lewis, G. B. & Hecker, J. F. (1985). Infusion thrombophlebitis. British Journal of Anaesthesia 57, 220-33.
3. Lanbeck, P., Odenholt, I. & Paulsen, O. (2002). Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scandinavian Journal of Infectious Diseases 34, 512-9.
4. Monreal, M., Quilez, F., Rey-Joly, C. et al. (1999). Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest 115, 1576-80.
5. Lanbeck, P. & Paulsen, O. (1995). Cytotoxic effects of four antibiotics on endothelial cells. Pharmacology & Toxicology 77, 365-70.
6. Lanbeck, P. & Paulsen, O. (2001). Short-term effects of four anti-biotics on DNA synthesis in endothelial cells. Pharmacology & Toxicology 88, 204-8.
7. Falchuk, K. H., Peterson, L. & McNeil, B. J. (1985). Microparticulate-induced phlebitis. Its prevention by in-line filtration. New England Journal of Medicine 312, 78-82.
8. Subrahmanyam, M. (1989). Intravenous placement device and infusion thrombophlebitis. Indian Journal of Medical Sciences 43, 27-31.
9. Woodhouse, C. R. (1980). Infusion thrombophlebitis: the histological and clinical features. Annals of the Royal College of Surgeons of England 62, 364-8.
10. Kuwahara, T., Asanami, S. & Kubo, S. (1998). Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 14, 496-501.
11. Carlos, T. M. & Harlan, J. M. (1994). Leukocyte-endothelial adhesion molecules. Blood 84, 2068-101.
12. Lidington, E. A., Moyes, D. L., McCormack, A. M. et al. (1999). A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transplant Immunology 7, 239-46.
13. Becker, B. F., Heindl, B., Kupatt, C. et al. (2000). Endothelial function and hemostasis. Zeitschrift für Kardiologie 89, 160-7.
14. Wada, H., Wakita, Y. & Shiku, H. (1995). Tissue factor expression in endothelial cells in health and disease. Blood Coagulation & Fibrinolysis 6, Suppl. 1, S26-31.
15. Riesbeck, K., Billstrom, A., Tordsson, J. et al. (1998). Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells. Clinical and Diagnostic Laboratory Immunology 5, 675-82.
16. Bierhaus, A., Zhang, Y., Deng, Y. et al. (1995). Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. Journal of Biological Chemistry 270, 26419-32.
17. de Dios Garcia-Diaz, J., Santolaya Perrin, R., Paz Martinez Ortega, M. et al. (2001). Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin. Medicina Clinica 116, 133-5.
18. Yalkowsky, S. H., Krzyzaniak, J. F. & Ward, G. H. (1998). Formulation-related problems associated with intravenous drug delivery. Journal of Pharmaceutical Sciences 87, 787-96.
19. Vorbach, H., Armbruster, C., Robibaro, B. et al. (2002). Endothelial cell compatibility of azithromycin and erythromycin. Journal of Antimicrobial Chemotherapy 49, 407-9.
20. Vorbach, H., Weigel, G., Robibaro, B. et al. (1998). Endothelial cell compatibility of clarithromycin for intravenous use. Clinical Biochemistry 31, 653-6.
21. Chee, S. & Tan, W. (2002). Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. Journal of Infusion Nursing 25, 95-104.
22. Gorgoulis, V. G., Zacharatos, P., Kotsinas, A. et al. (2003). p53 activates ICAM-1 (CD54) expression in an NF-κB-independent manner. EMBO Journal 22, 1567-78.
23. Prives, C. & Hall, P. A. (1999). The p53 pathway. Journal of Pathology 187, 112-26.
24. Takizawa, K., Kamijo, R., Ito, D. et al. (1999). Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway. British Journal of Cancer 80, 954-63.
25. Basi, D. L., Ross K. F., Hodges J. S. et al. (2003). The modulation of tissue factor by endothelial cells during heat shock. Journal of Biological Chemistry 278, 11065-71.
26. Hallahan, D. E., Virudachalam, S. & Kuchibhotla, J. (1998). Nuclear factor kB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium. Cancer Research 58, 5484-8.
27. Prabhakarpandian, B., Goetz, D. J., Swerlick, R. A. et al. (2001). Expression and functional significance of adhesion molecules on cultured endothelial cells in response to ionizing radiation. Microcirculation 8, 355-64.
28. Unger, R. E., Krump-Konvalinkova, V., Peters, K. et al. (2002). In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvascular Research 64, 384-97.
29. Altieri, D. C. (1999). Regulation of leukocyte-endothelium inter-action by fibrinogen. Thrombosis and Haemostasis 82, 781-6.
30. Tsakadze, N. L., Zhao, Z. & D'Souza, S. E. (2002). Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends in Cardiovascular Medicine 12, 101-8.